Cleared Traditional

K902150 - PIEZO HANDPIECE

K902150 is an FDA 510(k) clearance for PIEZO HANDPIECE, manufactured by United Surgical Corp.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 51-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1990
Decision
51d
Days
Class 2
Risk

K902150 is an FDA 510(k) clearance for the PIEZO HANDPIECE. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by United Surgical Corp. (Irvine, US). The FDA issued a Cleared decision on July 5, 1990 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K902150

510(k) Number K902150 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 1990
Decision Date July 05, 1990
Days to Decision 51 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 110d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K902150.
PHACOTRON SYSTEMS PLUS III PHACOEMULSIFIER ASPI.
K902876 · Intraoptics Surgical, Inc. · Sep 1990
THE PRECISIONIST
K900493 · Paradigm Medical, Inc. · Aug 1990
AUTOMATED HYDROSONICS(TM)
K902798 · Alcon Surgical, Inc. · Aug 1990
NIDEK/PHACO EMULSIFICATION SYSTEM MODEL CV-8000
K901686 · Nidek, Inc. · Jun 1990
MAGNETRON MUNICH MODEL ELECTRONIC CONTROL UNIT
K894511 · Intl. Ophthalmic Industries Corp. · Oct 1989
PHACOEMULSIFICATION UNIT TO REMOVE CATARAC. LENS
K894512 · Intl. Ophthalmic Industries Corp. · Oct 1989